Immunotherapy of melanoma

le Haanen, John B.A.G.
Foilsithe 2013

Questions asked in the everyday practice: immune checkpoint inhibitors

le Haanen, John B A G
Foilsithe in ESMO Open (2018)

Adoptive cellular therapies: the current landscape

le Rohaan, Maartje W., Wilgenhof, Sofie, Haanen, John B. A. G.
Foilsithe in Virchows Arch (2018)

Acquired and intrinsic resistance in cancer immunotherapy

le Kelderman, Sander, Schumacher, Ton N.M., Haanen, John B.A.G.
Foilsithe in Mol Oncol (2014)

Development of Ocular Rosacea following Combined Ipilimumab and Nivolumab Treatment for Metastatic Malignant Skin Melanoma

le Brouwer, Niels J., Haanen, John B.A.G., Jager, Martine J.
Foilsithe in Ocul Oncol Pathol (2017)

Naked Plasmid DNA Formulation: Effect of Different Disaccharides on Stability after Lyophilisation

le Quaak, Susanne G. L., Haanen, John B. A. G., Beijnen, Jos H., Nuijen, Bastiaan
Foilsithe 2010

Susceptible loci associated with autoimmune disease as potential biomarkers for checkpoint inhibitor-induced immune-related adverse events

le Hoefsmit, Esmée P., Rozeman, Elisa A., Haanen, John B. A. G., Blank, Christian U.
Foilsithe in ESMO Open (2019)

Selective Expansion of Cross-Reactive Cd8(+) Memory T Cells by Viral Variants

le Haanen, John B.A.G., Wolkers, Monika C., Kruisbeek, Ada M., Schumacher, Ton N.M.
Foilsithe 1999

Severe pan-uveitis in a patient treated with vemurafenib for metastatic melanoma

le Wolf, Sanne EJ, Meenken, Christina, Moll, Annette C, Haanen, John B, van der Heijden, Michiel S
Foilsithe in BMC Cancer (2013)

Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option

le Rohaan, Maartje W., van den Berg, Joost H., Kvistborg, Pia, Haanen, John B. A. G.
Foilsithe in J Immunother Cancer (2018)

Treatment With Tumor-infiltrating Lymphocytes in Advanced Melanoma: Evaluation of Early Clinical Implementation of an Advanced Therapy Medicinal Product

le Lindenberg, Melanie A., Retèl, Valesca P., van den Berg, Joost H., Geukes Foppen, Marnix H., Haanen, John B., van Harten, Wim H.
Foilsithe in J Immunother (2018)

Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8(+) T cells in influenza virus-infected mice

le Johnson, Barbara J., Costelloe, Elaine O., Fitzpatrick, David R., Haanen, John B. A. G., Schumacher, Ton N. M., Brown, Lorena E., Kelso, Anne
Foilsithe 2003

Response Prediction and Evaluation Using PET in Patients with Solid Tumors Treated with Immunotherapy

le Borm, Frank J., Smit, Jasper, Oprea-Lager, Daniela E., Wondergem, Maurits, Haanen, John B. A. G., Smit, Egbert F., de Langen, Adrianus J.
Foilsithe in Cancers (Basel) (2021)

Fixed Dosing of Monoclonal Antibodies in Oncology

le Hendrikx, Jeroen J.M.A., Haanen, John B.A.G., Voest, Emile E., Schellens, Jan H.M., Huitema, Alwin D.R., Beijnen, Jos H.
Foilsithe in Oncologist (2017)

Transgenerational transfer of gene-modified T cells

le Cosgrove, Cormac, Dellacecca, Emilia R., van den Berg, Joost H., Haanen, John B., Nishimura, Michael I., Le Poole, I. Caroline, Bergmans, Hans E. N.
Foilsithe in J Immunother Cancer (2019)

Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluation

le Retèl, Valesca P., Steuten, Lotte M. G., Geukes Foppen, Marnix H., Mewes, Janne C., Lindenberg, Melanie A., Haanen, John B. A. G., van Harten, Wim H.
Foilsithe in BMC Cancer (2018)

Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer

le Huijts, Charlotte M, Santegoets, Saskia J, van den Eertwegh, Alfons J, Pijpers, Laura S, Haanen, John B, de Gruijl, Tanja D, Verheul, Henk M, van der Vliet, Hans J
Foilsithe 2011

Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer

le Bense, Rico D., Sotiriou, Christos, Piccart-Gebhart, Martine J., Haanen, John B. A. G., van Vugt, Marcel A. T. M., de Vries, Elisabeth G. E., Schröder, Carolien P., Fehrmann, Rudolf S. N.
Foilsithe in J Natl Cancer Inst (2016)

The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial

le Huijts, Charlotte M., Lougheed, Sinéad M., Bodalal, Zuhir, van Herpen, Carla M., Hamberg, Paul, Tascilar, Metin, Haanen, John B., Verheul, Henk M., de Gruijl, Tanja D., van der Vliet, Hans J.
Foilsithe in Cancer Immunol Immunother (2019)

Manufacture of Gene-Modified Human T-Cells with a Memory Stem/Central Memory Phenotype

le Gomez-Eerland, Raquel, Nuijen, Bastiaan, Heemskerk, Bianca, van Rooij, Nienke, van den Berg, Joost H., Beijnen, Jos H., Uckert, Wolfgang, Kvistborg, Pia, Schumacher, Ton N., Haanen, John B.A.G., Jorritsma, Annelies
Foilsithe 2014